In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir

INTRODUCTION: Daclatasvir is a non-structural protein 5A (NS5A) inhibitor with activity against hepatitis C virus (HCV) genotypes 1–6 in vitro, and asunaprevir is a non-structural protein 3 (NS3) protease inhibitor with activity against genotypes 1, 4, 5, and 6. This study evaluates potential option...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Infect Dis Ther
Main Authors: Friborg, Jacques, Zhou, Nannan, Han, Zhou, Yang, Xiaoyan, Falk, Paul, Mendez, Patricia, McPhee, Fiona
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2014
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363215/
https://ncbi.nlm.nih.gov/pubmed/25516102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-014-0052-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados